Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-12-29
1997-05-27
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, A61K 3800, A61K 3827
Patent
active
056332289
ABSTRACT:
The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
REFERENCES:
patent: 4863902 (1989-09-01), Amagase et al.
patent: 5068224 (1991-11-01), Fryklund et al.
Apfel, et al. 1992. Ann. Neurol. 31:76-80.
Apfel, et al., "Nerve Growth Factor Prevents Toxic Neuropathy in Mice," Annals. of Neurology 29:87-90 (1991).
Aizerman et al. 1987 Brain Research 406:32-42.
Bothwell, "Insulin and Somatemedin MSA Promote Nerve Growth Factor-Independent Neurite Formation by Cultured Chick . . . Neurons," Journal of Neuroscience Research, 8:225-231 (1982).
Caroni, et al. 1990, Journal of Cell Biology, 110:1307-1317.
De Angelis et al. 1991, Cancer, 67:2241-2246.
Francis, et al. 1992, Art to Science in Tissue Culture, Hyclone Laboratories, Inc. 11:pp. 3, 5, 6, 7.
Hansson et al. 1986, Acta Physiol. Scand. 126:609-614.
Ishii et al., "In: Insulin, IGFs, and Their Receptors in the Central Nervous System (Raizada M.K. and Phillips M.A., eds)", Plenum Press. New York, pp. 315-348 (1987).
Legha, Sewa S. 1986. Medical Toxicology, 1:421-427.
Mengs et al. 1987, European Journal of Pharmacology, 142:419-424.
Olesen et al. 1991, Drug Safety, 6:302-314.
Recio-Pinto et al. 1988, Neurochem. Int. 12:387-414.
Ross et al. 1981, The Journal of Neuroscience, 1:1304-1311.
Shiraishi et al., "The Effect of Vincristine on Nerve Regeneration in the Rat: An Eletrophysiological Study," Journal of the Neurological Sciences, 71:9-17 (1985).
Apfel et al., "The Use of Insulin-Like Growth Factors in the Nervous Sytem," Annals of the New York Academy of Sciences, 692:243-243 (1992).
Lewis et al., "The Potential of Insulin-Like Growth Factor-I as a Therapeutic for the Treatment of Neuromuscular Disorders," Annals of the New York Academy of Sciences, 692:201-208 (1992).
Apfel Stuart C.
Kessler John A.
Lewis Michael E.
Albert Einstein College of Medicine of Yeshiva University
Cephalon Inc.
Touzeau P. Lynn
Tsang Cecilia J.
LandOfFree
Prevention and treatment of peripheral neuropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention and treatment of peripheral neuropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of peripheral neuropathy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329064